The University of Southampton
University of Southampton Institutional Repository

Re-classification of clinically-detected sequence variants: framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)

Re-classification of clinically-detected sequence variants: framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)
Re-classification of clinically-detected sequence variants: framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)

Purpose: Variant classifications may change over time, driven by emergence of fresh or contradictory evidence or evolution in weighing or combination of evidence items. For variant classifications above the actionability threshold, which is classification of likely pathogenic or pathogenic, clinical actions may be irreversible, such as risk-reducing surgery or prenatal interventions. Variant reclassification up or down across the actionability threshold can therefore have significant clinical consequences. Laboratory approaches to variant reinterpretation and reclassification vary widely. Methods: Cancer Variant Interpretation Group UK is a multidisciplinary network of clinical scientists and genetic clinicians from across the 24 Molecular Diagnostic Laboratories and Clinical Genetics Services of the United Kingdom (NHS) and Republic of Ireland. We undertook surveys, polls, and national meetings of Cancer Variant Interpretation Group UK to evaluate opinions about clinical and laboratory management regarding variant reclassification. Results: We generated a consensus framework on variant reclassification applicable to cancer susceptibility genes and other clinical areas, which provides explicit recommendations for clinical and laboratory management of variant reclassification scenarios on the basis of the nature of the new evidence, the magnitude of evidence shift, and the final classification score. Conclusion: In this framework, clinical and laboratory resources are targeted for maximal clinical effect and minimal patient harm, as appropriate to all resource-constrained health care settings.

Classification, Reclassification, Recontact, Reinterpretation, Variant
1098-3600
1867-1877
Loong, Lucy
a8745718-75a4-49a5-beac-ff8de8c2e854
Garrett, Alice
d8fcdea3-8231-4d5e-8ada-4f932ca1a0c3
Choi, Subin
beaa809f-6f77-487b-954f-9e2f336ba557
Durkie, Miranda
7caca497-e12f-4f13-99e0-f40e767f0163
Callaway, Alison
1ba2c719-a83b-4996-8d50-172de6356908
Drummond, James
15dae66f-25bc-4d38-8a4d-7f0368c384e9
Eccles, Diana
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Turnbull, Clare
63408861-754b-4f55-a010-29d1bea914e2
et al.
CanVIG-UK
Loong, Lucy
a8745718-75a4-49a5-beac-ff8de8c2e854
Garrett, Alice
d8fcdea3-8231-4d5e-8ada-4f932ca1a0c3
Choi, Subin
beaa809f-6f77-487b-954f-9e2f336ba557
Durkie, Miranda
7caca497-e12f-4f13-99e0-f40e767f0163
Callaway, Alison
1ba2c719-a83b-4996-8d50-172de6356908
Drummond, James
15dae66f-25bc-4d38-8a4d-7f0368c384e9
Eccles, Diana
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Turnbull, Clare
63408861-754b-4f55-a010-29d1bea914e2

Loong, Lucy, Garrett, Alice, Choi, Subin, Durkie, Miranda, Callaway, Alison, Drummond, James, Eccles, Diana, Lucassen, Anneke and Turnbull, Clare , et al. and CanVIG-UK (2022) Re-classification of clinically-detected sequence variants: framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK). Genetics in Medicine, 24 (9), 1867-1877. (doi:10.1016/j.gim.2022.05.002).

Record type: Article

Abstract

Purpose: Variant classifications may change over time, driven by emergence of fresh or contradictory evidence or evolution in weighing or combination of evidence items. For variant classifications above the actionability threshold, which is classification of likely pathogenic or pathogenic, clinical actions may be irreversible, such as risk-reducing surgery or prenatal interventions. Variant reclassification up or down across the actionability threshold can therefore have significant clinical consequences. Laboratory approaches to variant reinterpretation and reclassification vary widely. Methods: Cancer Variant Interpretation Group UK is a multidisciplinary network of clinical scientists and genetic clinicians from across the 24 Molecular Diagnostic Laboratories and Clinical Genetics Services of the United Kingdom (NHS) and Republic of Ireland. We undertook surveys, polls, and national meetings of Cancer Variant Interpretation Group UK to evaluate opinions about clinical and laboratory management regarding variant reclassification. Results: We generated a consensus framework on variant reclassification applicable to cancer susceptibility genes and other clinical areas, which provides explicit recommendations for clinical and laboratory management of variant reclassification scenarios on the basis of the nature of the new evidence, the magnitude of evidence shift, and the final classification score. Conclusion: In this framework, clinical and laboratory resources are targeted for maximal clinical effect and minimal patient harm, as appropriate to all resource-constrained health care settings.

Text
Loong_Variant_Reclassification_manuscript_MARKUP_sub4 - Accepted Manuscript
Download (123kB)
Text
Loong_Variant_reclassification_Table_1_sub4 - Accepted Manuscript
Download (21kB)
Text
1-s2.0-S1098360022007572-main - Proof
Available under License Creative Commons Attribution.
Download (540kB)

More information

Accepted/In Press date: 2 May 2022
e-pub ahead of print date: 3 June 2022
Published date: September 2022
Additional Information: Acknowledgements L.L., A.G., B.T., F.L. and H.H are supported by CRUK Catalyst Award CanGene-CanVar (C61296/A27223). D.G.E. and E.R.W. are supported by the all Manchester NIHR Biomedical Research Centre (IS-BRC-1215-20007). M.T. is supported by the Cambridge NIHR Biomedical Research Centre.
Keywords: Classification, Reclassification, Recontact, Reinterpretation, Variant

Identifiers

Local EPrints ID: 457158
URI: http://eprints.soton.ac.uk/id/eprint/457158
ISSN: 1098-3600
PURE UUID: a7f02415-37d0-4546-a19a-f3eb454b6ec4
ORCID for Diana Eccles: ORCID iD orcid.org/0000-0002-9935-3169
ORCID for Anneke Lucassen: ORCID iD orcid.org/0000-0003-3324-4338

Catalogue record

Date deposited: 25 May 2022 16:38
Last modified: 17 Mar 2024 07:20

Export record

Altmetrics

Contributors

Author: Lucy Loong
Author: Alice Garrett
Author: Subin Choi
Author: Miranda Durkie
Author: Alison Callaway
Author: James Drummond
Author: Diana Eccles ORCID iD
Author: Anneke Lucassen ORCID iD
Author: Clare Turnbull
Corporate Author: et al.
Corporate Author: CanVIG-UK

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×